WILMINGTON-  The Council for Development Finance convened to review and approve key funding motions aimed at pharmaceutical giant Merck, to establish their new facility in Wilmington.  In a meeting on Monday, Merck Sharp & Dohme LLC proposed a substantial $900 million biologics manufacturing facility in Wilmington. The company seeks $4.7 million in job performance grants and $25.5 million in capital …